BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Ischemia
,
Kidney
,
Laryngoscope
,
Tamoxifen
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prostaglandin e
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Pathophysiological role of prostaglandin E synthases in liver diseases.
Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin…
Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardi…
The microsomal prostaglandin E synthase-1/prostaglandin E2 axis induces recovery from ischaemia via …
The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Urinary PGE-MUM (PROSTAGLANDIN E-MAJOR URINARY METABOLITE) as Inflammatory Marker in Chronic Inflamm…
Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomark…
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
Prostaglandin Inhibition for Emphysema
Prostaglandin E1 in Outpatients With Intermittent Claudication
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ